# Radiotherapy Combined With QL1706 and Bevacizumab for Unresectable Non-metastatic Hepatocellular Carcinoma

> clinical trial · VERIFIED · 2026-08-03

Status: RECRUITING · Sponsor: Hebei Medical University Fourth Hospital · Condition: Hepatocellular Carcinoma

- Company: Hebei Medical University Fourth Hospital
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07179900

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.